Glutathione Peroxidase Activity, Plasma Total Antioxidant Capacity, and Urinary F2- Isoprostanes As Markers of Oxidative Stress in Anemic Dogs
Overview
Veterinary Medicine
Authors
Affiliations
Background: Oxidative stress plays a role in the pathophysiology of several diseases and has been documented as a contributor to disease in both the human and veterinary literature. One at-risk cell is the erythrocyte, however, the role of oxidative stress in anemia in dogs has not been widely investigated.
Hypothesis/objective: Anemic dogs will have an alteration in the activity of glutathione peroxidase (GPx), a decrease in of total antioxidant capacity (TAC), and an increased concentration of urinary 15-F -isoprostanes (F -IsoP) when compared to healthy dogs.
Animals: 40 client-owned dogs with anemia (PCV <30%) age-matched to 40 client-owned healthy control dogs.
Methods: Prospective, cross-sectional study. Whole blood GPx activity, plasma TAC, and urinary F -isoprostane concentrations were evaluated in each dog and compared between groups.
Results: Anemic dogs had significantly lower GPx activity (43.1 × 10 +/- 1.6 × 10 U/L) than did dogs in the control group (75.8 × 10 +/- 2.0 × 10 U/L; P < 0.0001). The GPx activity in dogs with hemolysis (10 +/- 0.8 × 10 U/L) was not significantly different (P = 0.57) than in dogs with nonhemolytic anemia (43.5 × 10 +/- 1.1 × 10 U/L). The TAC concentrations (P = 0.15) and urinary F -isoprostanes (P = 0.73) did not significantly differ between groups.
Conclusions And Clinical Importance: Glutathione peroxidase activity was significantly decreased in anemic dogs indicating oxidative stress. Additional studies are warranted to determine if antioxidant supplementation would improve survival and overall outcome as part of a therapeutic regimen for anemic dogs.
Ireland E, Sharp C, Leister E, Boyd S Front Vet Sci. 2025; 12:1500464.
PMID: 39963275 PMC: 11831891. DOI: 10.3389/fvets.2025.1500464.
Oxidative Stress in Canine Diseases: A Comprehensive Review.
Blanca P, Maria Luisa F, Guadalupe M, Fatima C Antioxidants (Basel). 2024; 13(11).
PMID: 39594538 PMC: 11591346. DOI: 10.3390/antiox13111396.
Perez-Montero B, Fermin-Rodriguez M, Miro G, Juan L, Cruz-Lopez F BMC Vet Res. 2023; 19(1):172.
PMID: 37741986 PMC: 10517482. DOI: 10.1186/s12917-023-03740-y.
Antioxidant Nanozymes: Mechanisms, Activity Manipulation, and Applications.
Thao N, Do H, Nhat Nam N, Tran N, Dan T, Trinh K Micromachines (Basel). 2023; 14(5).
PMID: 37241640 PMC: 10220853. DOI: 10.3390/mi14051017.
Potential mechanism for hyperhomocysteinemia in Greyhound dogs.
Johnson K, Tiedeman T, Peterson H, Steiner J, Trepanier L J Vet Intern Med. 2023; 37(3):960-967.
PMID: 37092349 PMC: 10229318. DOI: 10.1111/jvim.16700.